secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0000950170-25-027716
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro reports record FY2024 revenue $31.4M, 31% growth; guides FY2025 $36-41M
--------------------------------------------------------------------------------

- FY 2024 revenue $31.4M (+31% YoY); Q4 revenue $7.8M (+14% YoY).
- Gross margin improved to 61% from 57%; operating expenses rose 8% to $38.9M.
- Repaid $10M convertible note; cash $20.1M; operational cash burn down 35% to $9.0M.
- 2025 revenue guidance $36-41M, implying 15-31% growth.
- Biologics/drug delivery revenue up 76% to $18.6M; added 25 new centers in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000095017025027716/0000950170-25-027716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000095017025027716/clpt-20250226.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-027716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer